Frontlight ResearchEarly access
Trial site
New York University Medical Center PRIME
- 2running trials
- 3closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease4 trials
- Mild cognitive impairment2 trials
- Coeliac disease1 trial
- Phase
- Phase 33 trials
- Phase 22 trials
- Status
- Active, not recruiting2 trials
- Terminated2 trials
- Completed1 trial
- Lead sponsor
- Biogen3 trials
- Eisai Inc.1 trial
- Takeda1 trial
Running trials
Active, not recruiting
Active, not recruiting
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Closed trials
Completed
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Terminated
Site data: ClinicalTrials.govUpdated 13 Nov 2026